Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma (vol 692, 149344, 2024)

被引:0
|
作者
Ye, Xifu [1 ]
Deng, Junyuan [1 ]
Dong, Chengyuan [2 ]
Pan, Xue [3 ]
Lu, Yi [1 ]
机构
[1] Tongji Univ, Canc Ctr, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China
[2] Anhui Univ Sci & Technol, Med Coll, Huainan, Anhui, Peoples R China
[3] Soochow Univ, Affiliated Hosp 2, Dept Resp & Crit Care Med, Suzhou, Peoples R China
关键词
D O I
10.1016/j.bbrc.2024.150352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 33 条
  • [22] CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm
    Yao, Shucong
    Huang, Zixian
    Wei, Changji
    Wang, Yuepeng
    Xiao, Hongwei
    Chen, Shisheng
    Huang, Zhiquan
    BMC ORAL HEALTH, 2023, 23 (01)
  • [23] CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm
    Shucong Yao
    Zixian Huang
    Changji Wei
    Yuepeng Wang
    Hongwei Xiao
    Shisheng Chen
    Zhiquan Huang
    BMC Oral Health, 23
  • [24] CD98hc-A potential prognostic Biomarker for Therapeutic Response and therapeutic Target Molecule for Radiation Sensitization in Head and Neck Squamous Cell Carcinoma
    Digomann, D.
    Kurth, I
    Linge, A.
    Hein, L.
    Baumann, M.
    Dubrovska, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S25 - S26
  • [25] PI3K/RICTOR-mTORC2 axis as a driver of prognosis and potential druggable target in squamous cell lung carcinoma (SqCLC)
    Pilotto, S.
    Simbolo, M.
    Gkountakos, A.
    Vicentini, C.
    Sperduti, I.
    Ludovini, V.
    Chiari, R.
    Novello, S.
    Milella, M.
    Mafficini, A.
    Carbognin, L.
    Caregnato, E.
    Santo, A.
    Infante, M.
    Brunelli, M.
    Corbo, V.
    Scarpa, A.
    Tortora, G.
    Bria, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Identification and validation of Osteopontin and receptor for hyaluronic acid-mediated motility (RHAMM, CD168) for potential immunotherapeutic significance of in lung squamous cell carcinoma
    Gao, Shan
    Li, Meihe
    Kang, Minchao
    Zhao, Rui
    Wen, Xiaopeng
    Zhang, Guangjian
    Zheng, Jin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107
  • [27] Fructose-Bisphosphate Aldolase A Is a Potential Metastasis-Associated Marker of Lung Squamous Cell Carcinoma and Promotes Lung Cell Tumorigenesis and Migration (Expression of Concern of Vol 9, art no E85804, 2014)
    Du, S.
    Guan, Z.
    Hao, L.
    Song, Y.
    Wang, L.
    Gong, L.
    PLOS ONE, 2023, 18 (04):
  • [28] CDK11p11o plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target (vol 18, pg 452, 2019)
    Du, Yue
    Yan, Dan
    Yuan, Yongliang
    Xu, Jian
    Wang, Suhua
    Yang, Zhiheng
    Cheng, Weiyan
    Tian, Xin
    Kan, Quancheng
    CELL CYCLE, 2019, 18 (13) : 1523 - 1523
  • [29] RETRACTED: KIF18A is a potential prognostic factor and promotes tumor progression in oral tongue squamous cell carcinoma (Retracted article. See vol. 48, pg. 1009, 2024)
    Lv, Xiaofei
    Yu, Xi
    Xu, Jie
    Wang, Mingyi
    Peng, Cheng
    BIOCELL, 2022, 46 (05) : 1189 - 1196
  • [30] TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma (vol 14, e0216834, 2019)
    Li, Z.
    Jiang, C.
    Yuan, Y.
    PLOS ONE, 2019, 14 (06):